Amsterdam Neuroscience
-
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study
van der Lee, S. J., Visser, L. N. C., Cleutjens, S., van der Schaar, J., van Harten, A. C., Scheltens, P., Sikkes, S. A. M., van der Flier, W. M. & Zwan, M. D., 1 Dec 2024, In: Alzheimer's Research & Therapy. 16, 1, p. 1 1.Research output: Contribution to journal › Article › Academic › peer-review
-
Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time
Hendriksen, H. M. A., de Rijke, T. J., Fruijtier, A., van de Giessen, E., van Harten, A. C., van Leeuwenstijn-Koopman, M. S. S. A., van der Schaar, J., Visser, D., Smets, E. M. A., Visser, L. N. C. & van der Flier, W. M., 1 Aug 2024, (E-pub ahead of print) In: Alzheimer s & dementia.Research output: Contribution to journal › Article › Academic › peer-review
-
Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia
Alzheimer's Disease Neuroimaging Initiative (ADNI), 10 Jul 2024, In: Neurology. 103, 3, p. e209605 e209605.Research output: Contribution to journal › Article › Academic › peer-review
- All publications